Targeting of cytokine secreting lymphocytes (TCSL)

JANDUS Lab

The collaborative projects of Camilla Jandus' laboratory with the Department of oncology UNIL CHUV's Hi-TIDe* focus on the development of a pipeline relying on high-throughput technologies to identify critical determinants of “best in class” tumor-specific CD4 T cells, to exploit them in Phase I clinical trials of personalized ACT.
 

To learn more about Camila Jandus' work,visit :

*Human integrated Tumor Imunology Discovery engine, the laboratory of Pr George Coukos.

TOP ^

Follow us:  

CONTACT

Lausanne Oncology JANDUS affiliated lab-1.png

Camilla JANDUS
Ludwig adjunct scientist
Ludwig Institute for Cancer Research Lausanne

MD, PhD, Tenure Track Assistant Professor
Department of pathology and immunology
University of Geneva

Ludwig Lausanne RGB-crop461x374.jpg (Print)

Phone +41 22 379 54 40
Email

CONNECT WITH ME

WEB medallions Linked 150 x100-1.png

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
Ludwig Cancer Research Université de Lausanne Centre Hospitalier Universitaire Vaudois (CHUV)